BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2777410)

  • 1. HMFG1 antigen: a new marker for carcinomatous meningitis.
    Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
    Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
    Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
    Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
    Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
    Klee GG; Tallman RD; Goellner JR; Yanagihara T
    Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
    Hovestadt A; Henzen-Logmans SC; Vecht CJ
    Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
    Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
    Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma.
    Castro MP; McDonald TJ; Qualman SJ; Odorisio TM
    Cancer; 2001 Jun; 91(11):2122-6. PubMed ID: 11391593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
    Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
    JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.
    Zeller JA; Zunker P; Witt K; Schlueter E; Deuschl G
    Neurol Res; 2002 Oct; 24(7):652-4. PubMed ID: 12392200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinomatous meningitis revealing a cancer: study of two cases].
    Samet S; Belahsen F; Triki C; Masmoudi H; Jlidi R; Mhiri C
    Tunis Med; 2001 Apr; 79(4):257-60. PubMed ID: 11515489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.
    Moseley RP; Benjamin JC; Ashpole RD; Sullivan NM; Bullimore JA; Coakham HB; Kemshead JT
    J Neurol Neurosurg Psychiatry; 1991 Mar; 54(3):260-5. PubMed ID: 2030355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal carcinomatosis.
    Grossman SA; Krabak MJ
    Cancer Treat Rev; 1999 Apr; 25(2):103-19. PubMed ID: 10395835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
    Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
    Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer.
    Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinomatous meningitis presenting with isolated headache].
    Outteryck O; Berteloot D; Senechal O; Fromentin C; Mounier-Vehier F
    Rev Neurol (Paris); 2004 Oct; 160(10):949-51. PubMed ID: 15492724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.